An early trial of fluvoxamine to treat mild coronavirus disease 2019 (COVID-19) showed promising results, suggesting the antidepressant may help ward off clinical deterioration in patients with mild symptoms.
Study from the Journal of Hepatology aims to characterize immune responses associated with rapid natural clearance of HCV reinfection.
Pivmecillinam (Pivya) was given the nod from the federal agency, and is indicated for female adults with uncomplicated urinary tract infections (UTIs) caused by susceptible…
FDA recalls, allergy alerts, e coli & salmonella outbreaks, and more.
With this approval, aztreonam-avibactam becomes the first β-lactam/β-lactamase inhibitor antibiotic combination approved in the European Union for treating multidrug-resistant infections, including metallo-β-lactamase-producing bacteria.
Contagion® is a fully integrated news resource for practitioners and specialists to assist with the identification, diagnosis, treatment, and prevention of infectious diseases.
With this approval, aztreonam-avibactam becomes the first β-lactam/β-lactamase inhibitor antibiotic combination approved in the European Union for treating multidrug-resistant infections, including metallo-β-lactamase-producing bacteria.
Evaluating inpatient mortality for patients without supplemental oxygen at admission across different variants of concern periods with insights from Dr. Andre Kalil.
US Department of Agriculture’s Food Safety and Inspection Service (FSIS) issued a public health alert over the meat.
Contagion® is a fully integrated news resource for practitioners and specialists to assist with the identification, diagnosis, treatment, and prevention of infectious diseases.
Study by the Centers for Disease Control and Prevention (CDC) explores future directions for pediatric COVID-19 vaccination amid emerging variants.
